About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy

Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy: a Retrospective, Observational Study

NCT05616403•Tongji Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pancreatic Neoplasms

Interventions

No intervention

Locations

1

China

Locations (1)

Department of Biliary and Pancreatic Surgery, Tongji Hospital, Affiliated Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

Key Dates

Start Date

January 18, 2010

Primary Completion Date

August 28, 2016

Completion Date

January 15, 2021

Last Updated

November 15, 2022

Related Studies

RECRUITINGPhase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697

MesotheliomaNeoplasms+6 more

Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD

NCT07139236

Pancreatic NeoplasmsPancreatic Fistula

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

NCT07035587

Lung NeoplasmsPancreatic Neoplasms+6 more

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

NCT06953193

Pancreatic NeoplasmsHypotension+1 more

RECRUITINGPhase 1/2

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

NCT05218889

Pancreatic CancerPDAC - Pancreatic Ductal Adenocarcinoma+2 more

RECRUITINGPhase 2

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

NCT06538623

Pancreatic NeoplasmsNeoplasm Metastasis+1 more

View all related studies

Sponsors

Lead Sponsor

Tongji Hospital

Collaborators

West China Hospital
The Second Hospital of Hebei Medical University
Hunan Provincial People's Hospital
Guangdong Provincial Hospital of Traditional Chinese Medicine
Chinese PLA General Hospital
Sir Run Run Shaw Hospital
The Affiliated Hospital of Xuzhou Medical University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
First Affiliated Hospital of Chongqing Medical University
Fujian Medical University Union Hospital
The First Affiliated Hospital with Nanjing Medical University
Nanjing Medical University
The First Hospital of Jilin University
Zhejiang University
Huadong Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 15, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions